TransMedics Group, Inc. is a small-cap company disrupting the healthcare market with its innovative Organ Care System and National OCS Program. TransMedics recently acquired Summit Aviation as the com
ANDOVER, Mass. , April 16, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end
TransMedics (TMDX) reachead $91.82 at the closing of the latest trading day, reflecting no change compared to its last close.
Whether you believe them or not, analyst ratings have long been a strong indicator of the stock price's direction. There is a direct correlation between how Wall Street analysts rate a stock and how i
The bull market continues, and the S&P 500 is hardly giving up any gains. Indeed, the momentum from the October 2023 lows has been incredible.
ANDOVER, Mass. , April 8, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
ANDOVER, Mass. , March 19, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end
FY2023: TransMedics' revenues up 159%, profitability improves, breakeven could be on the horizon. Potential 2x top-line growth medium term in the U.S. alone. TransMedics' Organ Care System (OCS) could
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
TransMedics Group is transforming the organ transplant landscape with its expansive transplant solutions. The company has a proven technology, FDA approved, making it a rare early commercial-stage inv
The stock market keeps reaching new heights, but you can still find terrific growth stocks trading for reasonable prices. PubMatic's supply-side advertising platform generates a strong profit, and it
Eli Lilly has been one of the hottest names in healthcare thanks to its anti-obesity and diabetes treatments. TransMedics has been more than doubling sales and expects around 50% revenue growth this y
ANDOVER, Mass. , Feb. 28, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
TransMedics Group, Inc. (TMDX) Q4 2023 Earnings Call Transcript

TransMedics: A Very Expensive Growth Stock

10:28am, Wednesday, 07'th Feb 2024
TransMedics has a dominant market position in the organ transplant market due to its revolutionary Organ Care System product, which helps organs survive longer, enabling significantly greater reach. A
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE